Use of Recombinant α-2b-Interferon in the Treatment of Acute Respiratory Viral Diseases in Children

Abstract

The article describes the types and biological features of interferons, which are the part of the child’s body antiviral defense. There are shown the possibilities of using interferons, in particular, α-2b-interferon (Laferobion), in the comprehensive treatment of acute respiratory viral infections in children since the neonatal period.

Keywords

• recombinant α-2b-interferon
• acute respiratory viral diseases
• children